MX342979B - Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica. - Google Patents

Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica.

Info

Publication number
MX342979B
MX342979B MX2013014487A MX2013014487A MX342979B MX 342979 B MX342979 B MX 342979B MX 2013014487 A MX2013014487 A MX 2013014487A MX 2013014487 A MX2013014487 A MX 2013014487A MX 342979 B MX342979 B MX 342979B
Authority
MX
Mexico
Prior art keywords
actinic keratosis
photolyase
improving
reducing
subclinical
Prior art date
Application number
MX2013014487A
Other languages
English (en)
Other versions
MX2013014487A (es
Inventor
Ramón Trullas Cabanas Carlos
Puig I Sarda Susana
Malvehy Guilera Josep
Original Assignee
Inst D'investigacions Biomèdiques August Pi I Sunyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES201130965A external-priority patent/ES2393338B1/es
Priority claimed from ES201131696A external-priority patent/ES2402523B1/es
Application filed by Inst D'investigacions Biomèdiques August Pi I Sunyer filed Critical Inst D'investigacions Biomèdiques August Pi I Sunyer
Publication of MX2013014487A publication Critical patent/MX2013014487A/es
Publication of MX342979B publication Critical patent/MX342979B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de enzimas del tipo fotoliasa para reducir o mejorar el campo de cancerización cutáneo subclínico que se asocia a la queratosis actínica o al cáncer de piel no melanoma (NMSC) y a métodos para el tratamiento terapéutico del campo de cancerización subclínico que se asocia a la queratosis actínica y/o al cáncer de piel no melanoma (NMSC).
MX2013014487A 2011-06-09 2012-06-08 Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica. MX342979B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES201130965A ES2393338B1 (es) 2011-06-09 2011-06-09 Uso de fotoliasa para la reducción o mejora del campo de cancerización subclínico asociado a la queratosis actínica.
US201161502653P 2011-06-29 2011-06-29
ES201131696A ES2402523B1 (es) 2011-10-21 2011-10-21 Uso de fotoliasa para la reducción o mejora del campo de cancerización subclínico asociado a la queratosis actínica
PCT/EP2012/060852 WO2012168401A1 (en) 2011-06-09 2012-06-08 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis

Publications (2)

Publication Number Publication Date
MX2013014487A MX2013014487A (es) 2014-10-13
MX342979B true MX342979B (es) 2016-10-19

Family

ID=47295517

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014487A MX342979B (es) 2011-06-09 2012-06-08 Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica.

Country Status (9)

Country Link
US (1) US10124044B2 (es)
EP (1) EP2717907B1 (es)
AR (1) AR088127A1 (es)
AU (1) AU2012266328B2 (es)
BR (1) BR112013030807A2 (es)
ES (1) ES2545855T3 (es)
MX (1) MX342979B (es)
PT (1) PT2717907E (es)
WO (1) WO2012168401A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015026702A2 (pt) * 2013-04-21 2018-02-06 Yeda Res And Developmente Co Ltd métodos de extermínio de células senescentes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077211A (en) 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes

Also Published As

Publication number Publication date
AU2012266328A1 (en) 2014-01-09
EP2717907A1 (en) 2014-04-16
AR088127A1 (es) 2014-05-14
BR112013030807A2 (pt) 2018-04-24
US10124044B2 (en) 2018-11-13
US20140255469A1 (en) 2014-09-11
MX2013014487A (es) 2014-10-13
AU2012266328B2 (en) 2016-06-23
PT2717907E (pt) 2015-08-28
WO2012168401A1 (en) 2012-12-13
EP2717907B1 (en) 2015-05-27
ES2545855T3 (es) 2015-09-16

Similar Documents

Publication Publication Date Title
ECSP13012978A (es) Inhibidores de glucosilceramida sintasa
WO2015009726A3 (en) Medical uses of cd38 agonists
IN2014DN10386A (es)
MX370573B (es) Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
GB2503852A (en) Compounds for the treatment of neuropsychiatric disorders
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
PH12018501443A1 (en) Methods of administering hepcidin
MX2015003701A (es) Composiciones para tratamiento.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
AU2013357030A8 (en) Chlorin derivative useful in photodynamic therapy and diagnosis
EA201391702A1 (ru) Интраназальные тестостероновые составы с пониженной дозировкой в виде геля и их применение для лечения аноргазмии или гипоактивного расстройства сексуального желания
MX341020B (es) Peptidos derivados de lactoferrina humana y su uso.
MX2015012580A (es) El uso de sdf-1 para atenuar la formacion de cicatrices.
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
IN2014DN00123A (es)
MX342239B (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
NZ701974A (en) Novel therapeutic treatments with anti-her2 antibodies having a low fucosylation
MX347245B (es) Composiciones para el tratamiento de úlceras periféricas de diversos orígenes.
MX2013014420A (es) Composiciones en gel.
PH12019501358A1 (en) Methods of administering hepcidin
MX342979B (es) Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica.
EP2686001A4 (en) USES OF MODIFIED ELR-CXC-MODIFIED G31P CHEMOKINE FOR TREATING CANCER
MX2011007384A (es) Terapias de combinacion para trastornos neoplásticos.
NZ705229A (en) Pharmaceutical formulations containing ipidacrine and their use for the treatment of disorders of potency and disorders of other forms of sexual activity

Legal Events

Date Code Title Description
FG Grant or registration